Immunotherapy and cell therapy have revolutionized the field of cancer treatment by harnessing the power of the immune system to fight cancer cells. However, the development of effective immunotherapy drugs such as immune checkpoint inhibitors requires extensive preclinical testing to ensure safety and efficacy. Breakthroughs in the field are faced with several challenges including the generation of appropriate humanized mouse models for preclinical evaluation. Among others, genetically-engineered mouse models have emerged as valuable tools for improving cancer treatment outcomes.
Genetically Engineered Humanized Mouse Models: A Critical Tool for Studying Immunotherapy Drugs
July 13, 2023
- Live Dead Measurement and Cell Viability
- To Fc or not Fc: An assay for the question
- Fc Receptors (FcR) and their Relevance to Flow Cytometry
- Large Panel Design to Identify Human and Mouse Lymphocyte Subsets Using Cytek® Aurora Flow Cytometers
- Featured Guest Blog: Cardiac Stem Cells by Darcey L. Clark
Live Dead Measurement and Cell Viability
By Marrisssa Bailey, BS
To Fc or not Fc: An assay for the question
By Shalina Prasad BS
Fc Receptors (FcR) and their Relevance to Flow Cytometry
By Jennifer J. Stewart PhD
Get Started
Contact Us Today!
If you’re looking for an expert team to guide your trial with efficiency in mind, we can help. As the creators of the Dynamic Trial, TD2 provides start-to-finish support with trial strategy, design and execution for faster go-to-market potential.